Cargando…
New opportunities for nanoparticles in cancer immunotherapy
BACKGROUND: Recently, cancer immunotherapy has become standard for cancer treatment. Immunotherapy not only treats primary tumors, but also prevents metastasis and recurrence, representing a major advantage over conventional cancer treatments. However, existing cancer immunotherapies have limited cl...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158870/ https://www.ncbi.nlm.nih.gov/pubmed/30275967 http://dx.doi.org/10.1186/s40824-018-0133-y |